U.S. Renal Care South Bay Home Program in Torrance, California - Dialysis Center

U.S. Renal Care South Bay Home Program is a medicare approved dialysis facility center in Torrance, California and it has 4 dialysis stations. It is located in Los Angeles county at 23441 Madison Street #320, Torrance, CA, 90503. You can reach out to the office of U.S. Renal Care South Bay Home Program at (310) 378-8452. This dialysis clinic is managed and/or owned by Us Renal Care, Inc.. U.S. Renal Care South Bay Home Program has the following ownership type - Profit. It was first certified by medicare in April, 2016. The medicare id for this facility is 552784 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameU.S. Renal Care South Bay Home Program
Location23441 Madison Street #320, Torrance, California
No. of Dialysis Stations 4
Medicare ID552784
Managed ByUs Renal Care, Inc.
Ownership TypeProfit
Late Shifts No

Contact Information


23441 Madison Street #320, Torrance, California, 90503
(310) 378-8452
Not Available

News Archive

Associates at SJRMC's new hospital in Mishawaka now have access to on-site concierge service

Associates at Saint Joseph Regional Medical Center's (SJRMC) new hospital in Mishawaka, Ind., now have access to an on-site concierge service provided by Best Upon Request, a national organization based in Cincinnati.

Scientists develop new predictive model to help identify sudden cardiac death

Researchers from Emory's Rollins School of Public Health developed a sudden cardiac death (SCD) predictive model that can help identify and prevent the disease in individuals at high risk.

Notch activation determines signals necessary to generate hematopoietic stem cells in laboratory

An international study led by researchers from IMIM (Hospital del Mar Medical Research Institute) published in the journal Nature Communications has revealed that the intensity or efficiency of the activation of a protein called Notch, which is involved in the different phases of embryonic development, determines the fate of cells, i.e. if cells will form the aorta artery or blood (hematopoietic) stem cells. For artery cells, many Notch molecules need to be activated, whereas for hematopoietic cells many fewer are needed.

KV Pharmaceutical to continue trading on NYSE till March 31, 2010

KV Pharmaceutical Company ( KVa/KVb) (the "Company") received permission from the New York Stock Exchange (the "Exchange") for its securities to continue to trade on the Exchange until March 31, 2010 while the Company prepares its Annual Report on Form 10-K for the Company's fiscal year ended March 31, 2009 (the "2009 Annual Report").

News briefs from featured presentations at Cardiology 2012

Pediatric cardiology researchers and clinicians from almost 50 centers from across the U.S. and around the world are gathering at the Cardiology 2012 Conference sponsored by The Children's Hospital of Philadelphia on Feb. 22-26 in Orlando, Fla.

Read more Medical News

› Verified 7 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with U.S. Renal Care South Bay Home Program from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1528466331
Organization NameU.s. Renal Care South Bay Home Program
Doing Business AsUsrc Torrance Home Program, Llc
Address23441 Madison St Torrance, California, 90505
Phone Number(310) 375-7173

News Archive

Associates at SJRMC's new hospital in Mishawaka now have access to on-site concierge service

Associates at Saint Joseph Regional Medical Center's (SJRMC) new hospital in Mishawaka, Ind., now have access to an on-site concierge service provided by Best Upon Request, a national organization based in Cincinnati.

Scientists develop new predictive model to help identify sudden cardiac death

Researchers from Emory's Rollins School of Public Health developed a sudden cardiac death (SCD) predictive model that can help identify and prevent the disease in individuals at high risk.

Notch activation determines signals necessary to generate hematopoietic stem cells in laboratory

An international study led by researchers from IMIM (Hospital del Mar Medical Research Institute) published in the journal Nature Communications has revealed that the intensity or efficiency of the activation of a protein called Notch, which is involved in the different phases of embryonic development, determines the fate of cells, i.e. if cells will form the aorta artery or blood (hematopoietic) stem cells. For artery cells, many Notch molecules need to be activated, whereas for hematopoietic cells many fewer are needed.

KV Pharmaceutical to continue trading on NYSE till March 31, 2010

KV Pharmaceutical Company ( KVa/KVb) (the "Company") received permission from the New York Stock Exchange (the "Exchange") for its securities to continue to trade on the Exchange until March 31, 2010 while the Company prepares its Annual Report on Form 10-K for the Company's fiscal year ended March 31, 2009 (the "2009 Annual Report").

News briefs from featured presentations at Cardiology 2012

Pediatric cardiology researchers and clinicians from almost 50 centers from across the U.S. and around the world are gathering at the Cardiology 2012 Conference sponsored by The Children's Hospital of Philadelphia on Feb. 22-26 in Orlando, Fla.

Read more Medical News

› Verified 7 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data7

News Archive

Associates at SJRMC's new hospital in Mishawaka now have access to on-site concierge service

Associates at Saint Joseph Regional Medical Center's (SJRMC) new hospital in Mishawaka, Ind., now have access to an on-site concierge service provided by Best Upon Request, a national organization based in Cincinnati.

Scientists develop new predictive model to help identify sudden cardiac death

Researchers from Emory's Rollins School of Public Health developed a sudden cardiac death (SCD) predictive model that can help identify and prevent the disease in individuals at high risk.

Notch activation determines signals necessary to generate hematopoietic stem cells in laboratory

An international study led by researchers from IMIM (Hospital del Mar Medical Research Institute) published in the journal Nature Communications has revealed that the intensity or efficiency of the activation of a protein called Notch, which is involved in the different phases of embryonic development, determines the fate of cells, i.e. if cells will form the aorta artery or blood (hematopoietic) stem cells. For artery cells, many Notch molecules need to be activated, whereas for hematopoietic cells many fewer are needed.

KV Pharmaceutical to continue trading on NYSE till March 31, 2010

KV Pharmaceutical Company ( KVa/KVb) (the "Company") received permission from the New York Stock Exchange (the "Exchange") for its securities to continue to trade on the Exchange until March 31, 2010 while the Company prepares its Annual Report on Form 10-K for the Company's fiscal year ended March 31, 2009 (the "2009 Annual Report").

News briefs from featured presentations at Cardiology 2012

Pediatric cardiology researchers and clinicians from almost 50 centers from across the U.S. and around the world are gathering at the Cardiology 2012 Conference sponsored by The Children's Hospital of Philadelphia on Feb. 22-26 in Orlando, Fla.

Read more Medical News

› Verified 7 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center44
    Adult patient months included in Kt/V greater than or equal to 1.7325
    Percentage of adult patients getting regular peritoneal dialysis at the center86
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Associates at SJRMC's new hospital in Mishawaka now have access to on-site concierge service

    Associates at Saint Joseph Regional Medical Center's (SJRMC) new hospital in Mishawaka, Ind., now have access to an on-site concierge service provided by Best Upon Request, a national organization based in Cincinnati.

    Scientists develop new predictive model to help identify sudden cardiac death

    Researchers from Emory's Rollins School of Public Health developed a sudden cardiac death (SCD) predictive model that can help identify and prevent the disease in individuals at high risk.

    Notch activation determines signals necessary to generate hematopoietic stem cells in laboratory

    An international study led by researchers from IMIM (Hospital del Mar Medical Research Institute) published in the journal Nature Communications has revealed that the intensity or efficiency of the activation of a protein called Notch, which is involved in the different phases of embryonic development, determines the fate of cells, i.e. if cells will form the aorta artery or blood (hematopoietic) stem cells. For artery cells, many Notch molecules need to be activated, whereas for hematopoietic cells many fewer are needed.

    KV Pharmaceutical to continue trading on NYSE till March 31, 2010

    KV Pharmaceutical Company ( KVa/KVb) (the "Company") received permission from the New York Stock Exchange (the "Exchange") for its securities to continue to trade on the Exchange until March 31, 2010 while the Company prepares its Annual Report on Form 10-K for the Company's fiscal year ended March 31, 2009 (the "2009 Annual Report").

    News briefs from featured presentations at Cardiology 2012

    Pediatric cardiology researchers and clinicians from almost 50 centers from across the U.S. and around the world are gathering at the Cardiology 2012 Conference sponsored by The Children's Hospital of Philadelphia on Feb. 22-26 in Orlando, Fla.

    Read more Medical News

    › Verified 7 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at U.S. Renal Care South Bay Home Program with elevated calcium levels.

Patients with hypercalcemia44
Hypercalcemia patient months325
Hypercalcemia patients with serumcalcium greater than 10.2 mg3
Patients with Serumphosphor48
Patients with Serumphosphor less than 3.5 mg/dL3
Patients with Serumphosphor from 3.5 to 4.5 mg/dL24
Patients with Serumphosphor from 4.6 to 5.5 mg/dL36
Patients with Serumphosphor from 5.6 to 7 mg/dL22
Patients with Serumphosphor greater than 7 mg/dL15

News Archive

Associates at SJRMC's new hospital in Mishawaka now have access to on-site concierge service

Associates at Saint Joseph Regional Medical Center's (SJRMC) new hospital in Mishawaka, Ind., now have access to an on-site concierge service provided by Best Upon Request, a national organization based in Cincinnati.

Scientists develop new predictive model to help identify sudden cardiac death

Researchers from Emory's Rollins School of Public Health developed a sudden cardiac death (SCD) predictive model that can help identify and prevent the disease in individuals at high risk.

Notch activation determines signals necessary to generate hematopoietic stem cells in laboratory

An international study led by researchers from IMIM (Hospital del Mar Medical Research Institute) published in the journal Nature Communications has revealed that the intensity or efficiency of the activation of a protein called Notch, which is involved in the different phases of embryonic development, determines the fate of cells, i.e. if cells will form the aorta artery or blood (hematopoietic) stem cells. For artery cells, many Notch molecules need to be activated, whereas for hematopoietic cells many fewer are needed.

KV Pharmaceutical to continue trading on NYSE till March 31, 2010

KV Pharmaceutical Company ( KVa/KVb) (the "Company") received permission from the New York Stock Exchange (the "Exchange") for its securities to continue to trade on the Exchange until March 31, 2010 while the Company prepares its Annual Report on Form 10-K for the Company's fiscal year ended March 31, 2009 (the "2009 Annual Report").

News briefs from featured presentations at Cardiology 2012

Pediatric cardiology researchers and clinicians from almost 50 centers from across the U.S. and around the world are gathering at the Cardiology 2012 Conference sponsored by The Children's Hospital of Philadelphia on Feb. 22-26 in Orlando, Fla.

Read more Medical News

› Verified 7 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary6
Hospitalization Rate in facility (Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit

News Archive

Associates at SJRMC's new hospital in Mishawaka now have access to on-site concierge service

Associates at Saint Joseph Regional Medical Center's (SJRMC) new hospital in Mishawaka, Ind., now have access to an on-site concierge service provided by Best Upon Request, a national organization based in Cincinnati.

Scientists develop new predictive model to help identify sudden cardiac death

Researchers from Emory's Rollins School of Public Health developed a sudden cardiac death (SCD) predictive model that can help identify and prevent the disease in individuals at high risk.

Notch activation determines signals necessary to generate hematopoietic stem cells in laboratory

An international study led by researchers from IMIM (Hospital del Mar Medical Research Institute) published in the journal Nature Communications has revealed that the intensity or efficiency of the activation of a protein called Notch, which is involved in the different phases of embryonic development, determines the fate of cells, i.e. if cells will form the aorta artery or blood (hematopoietic) stem cells. For artery cells, many Notch molecules need to be activated, whereas for hematopoietic cells many fewer are needed.

KV Pharmaceutical to continue trading on NYSE till March 31, 2010

KV Pharmaceutical Company ( KVa/KVb) (the "Company") received permission from the New York Stock Exchange (the "Exchange") for its securities to continue to trade on the Exchange until March 31, 2010 while the Company prepares its Annual Report on Form 10-K for the Company's fiscal year ended March 31, 2009 (the "2009 Annual Report").

News briefs from featured presentations at Cardiology 2012

Pediatric cardiology researchers and clinicians from almost 50 centers from across the U.S. and around the world are gathering at the Cardiology 2012 Conference sponsored by The Children's Hospital of Philadelphia on Feb. 22-26 in Orlando, Fla.

Read more Medical News

› Verified 7 days ago